SQZ Biotechnologies Company / Fundamentals
Income statement
- Net revenue
€10.46M - Cost of goods sold
€0.00 - Gross profit
€10.46M - SG&A expenses
€18.00M - R&D expenses
€44.44M - EBITDA
-€51.18M - D&A
€11.59M - EBIT
-€62.80M - Interest expenses
€0.00 - EBT
-€41.19M - Tax expenses
-€38.56M - Net income
-€2.91M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€3.43M - Changes in working capital
-€20.58M - Operating cash flow
-€47.98M - Capex
€182.75K - Other investing cash flow
€132.99K - Net investing cash flow
-€49.76K - Total cash dividends paid
€0.00 - Issuance of common stock
€261.69K - Debt repayment
€0.00 - Other financing cash flow
€284.00K - Net financing cash flow
€284.00K - Foreign exchange effects
€0.00 - Net change in cash
-€47.74M - Cash at end of period
€3.33M - Free cash flow
-€47.79M
Balance sheet
- Cash and cash equivalents
€8.75M - Cash and short-term investments
€8.75M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€1.63M - Total current assets
€10.37M - Property, plant & equipment
€13.21M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€1.98M - Total non-current assets
€15.19M - Total assets
€25.56M - Accounts payable
€1.64M - Short-term debt
€2.06M - Other current liabilities
€3.88M - Total current liabilities
€7.58M - Long-term debt
€16.37M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€16.37M - Total liabilities
€23.94M - Common stock
€24.88K - Retained earnings
-€285.77M - Other equity
€0.00 - Total equity
€1.61M - Total liabilities and shareholders' equity
€25.56M
Company information
- Market capitalization
€10.94M - Employees
53 - Enterprise Value
-€35.35M
Company ratios
- Gross margin
-
100.0% Much better than peer group: -2,045.7% - EBITDA margin
-
-489.1% Much better than peer group: -10,204.0% - EBIT margin
-
-600.1% Much better than peer group: -11,109.6% - EBT margin
-
-393.6% Much better than peer group: -8,608.6% - Net margin
-
-27.9% Much better than peer group: -7,667.1% - ROE
-
-180.6% Much worse than peer group: -102.8% - ROA
-
-11.4% Much better than peer group: -393.7% - Asset turnover
-
40.9% Even with peer group: 37.3% - FCF margin
-
-460.2% Much better than peer group: -10,118.1% - FCF yield
-440.1% - Efficiency ratio
589.1% - Net sales per employee
-
€197.44K - Net income per employee
-
-€54.99K